Therapeutic approaches in the treatment of ligneous conjunctivitis, the most common clinical manifestation of a systemic disease, caused by severe type I plasminogen deficiency

Am J Ophthalmol. 2004 Oct;138(4):699; author reply 699-700. doi: 10.1016/j.ajo.2004.05.054.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Amnion / transplantation
  • Biological Dressings
  • Conjunctivitis / etiology
  • Conjunctivitis / surgery
  • Conjunctivitis / therapy*
  • Female
  • Humans
  • Plasminogen / deficiency*
  • Plasminogen / therapeutic use*
  • Thrombolytic Therapy*

Substances

  • Plasminogen